Organogenesis Holdings Inc (ORGO) stock saw a decline, ending the day at $2.83 which represents a decrease of $-0.10 or -3.41% from the prior close of $2.93. The stock opened at $2.87 and touched a ...

Lake Street has recently initiated Organogenesis Holdings Inc (ORGO) stock to Buy rating, as announced on June 28, 2024, according to Finviz. Earlier, on February 7, 2024, Cantor Fitzgerald had ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to ...

Dozens of labs around the world are striving to grow models of human embryos to study development, fertility and therapies.

Studying human embryonic development is complicated for several reasons. Models derived from pluripotent stem cells ...

As of September 13, 2024, Organogenesis Holdings Inc had a $346.0 million market capitalization, putting it in the 50th percentile of companies in the Biotechnology & Medical Research industry.

Researchers have made a significant breakthrough in understanding the role of microRNAs in bamboo’s de novo shoot ...

According to the Ozempic prescribing information, you should stop taking Ozempic at least two months before a planned ...

Report on how AI is redefining market landscape- The global amniotic membrane market size is estimated to grow by US ...

Explore the benefits of automation in plant tissue culture and learn about common technical challenges and solutions for ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...